Economía de la Salud


Opciones: Vista Forum

Use Proportional Font
Por defecto enseñar Text Part
Mostrar todas las cabeceras de correo

Mensaje: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Tema: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Autor: [<< Primero] [< Prev] [Siguiente >] [Último >>]

Print Responder
AES ECONSALUD <[log in para visualizar]>
Reply To:
Economía de la Salud <[log in para visualizar]>
Thu, 26 Sep 2019 21:26:51 +0200
text/plain (35 lines)
Symposium - Pharmaceutical policies in the long run (11 Nov 2019, Merton College Oxford)

Symposium: Pharmaceutical policies in the long run: Reflections on 60th anniversary of the Hinchliffe Report

A symposium to mark the 60th anniversary of the Hinchliffe Report - a Government Committee tasked with examining the rise in pharmaceutical expenditure following the introduction of the NHS.

Its recommendations were far-reaching including:

• Improvements in the training of GPs to understand evidence regarding the use of new drugs and the economics of prescribing;
• Routinely conducting clinical trials to assess drugs and to publish results in an independent prescribers’ journal;
•  Development of an expert body that would be informed by research on economic and social aspects of the NHS;
• An examination of the economics of drug development, marketing and pharmacy to ensure efficiency and equity in prescribing;

The purpose of the workshop is firstly to reflect on the report in order to understand the degree to which we face similar challenges today, and the degree to which we have been able to address these challenges. Secondly, if a Government was to commission a report to look at pharmaceutical expenditure today, what potential long-term recommendations could be made to address current challenges?

Confirmed speakers include

Dr Amanda Adler, Chair of NICE Appraisal Committee and Consultant Physician
Prof Darrin Baines, Bournemouth University
Prof Philip Clarke, Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford
Prof Sir Rory Collins, Prof Louise Bowman, Clinical Trials at the Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford
Sir Andrew Dillon, CEO, National Institute for Health and Care Excellence
Dr Elaine Kelly, Senior Research Economist, Institute of Fiscal Studies and the Health Foundation
Prof Martin Landary, Big Data Institute, Nuffield Department of Population Health, University of Oxford
Mr Danny Palnoch, Head of Medicines Analysis, Strategy and Policy, NHS England
Prof Adrian Towse, Office of Health Economics
Dr Beth Woods, Centre for Health Economics, University York.

Early bird Corporate/Industry - £200
Early bird Academic/Public Sector - £100
PhD student rates £55.

More information and online bookings